Anthropic Says It Will Revolutionize Biology--Some Day

In breathless press releases and posts, the company has touted its models' ability to deliver scientific breakthroughs. But its IPO filing taps the brakes on just how fast its AI will lead to big discoveries. AI giant Anthropic and CEO Dario Amodei have repeatedly claimed that the company's models will revolutionize biology and drug discovery . But in its IPO filing Monday, Anthropic struck a humbler note, acknowledging its lack of experience in physical experimentation and the potential pitfalls of drug development. Wherever it's going, it seems, it will take some time to get there.